21:50 , Oct 5, 2017 |  BC Innovations  |  Translation in Brief

Chronic neuroprotection

Two studies by Genentech have shown DLK inhibition is neuroprotective in two chronic neurodegenerative diseases and suggest the target may play a broad role in driving neurodegeneration, regardless of the underlying cause. MAP kinase kinase...